產(chǎn)品描述: | SR-3677 is a potent and selective ROCK-II inhibitor with an IC50 of ~3 nM. |
靶點(diǎn): |
ROCK-II:3 nM (IC50);ROCK-I:56 nM (IC50);ROCK;?Autophagy |
體內(nèi)研究: |
ExVivo: Pharmacology studies shows that SR-3677 is efficacious in both, increasing ex vivo aqueous humor outflow in porcine eyes and inhibiting myosin light chain phosphorylation. Continuous exposure of 25 μM SR-3677 increases the outflow facility by 60% at 1 h perfusion, increasing to 70–80% for the 2–5 h time points |
參考文獻(xiàn): |
1. Feng Y, et al. Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors. J Med Chem. 2008 Nov 13;51(21):6642-5. |
溶解性: |
DMSO : 100 mg/mL (244.83 mM; Need ultrasonic) |
保存條件: |
RT |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
2.448 ml |
12.241 ml |
24.483 ml |
5 mM |
0.49 ml |
2.448 ml |
4.897 ml |
10 mM |
0.245 ml |
1.224 ml |
2.448 ml |
50 mM |
0.049 ml |
0.245 ml |
0.49 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。 |